Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.
Medicines Discovery Catapult logo.

Share this

The mission of Medicines Discovery Catapult is to accelerate drug discovery and help transform ideas into better medicines for patients, faster. To enable this, Medicines Discovery Catapult are mapping, curating and using national networks to help SMEs and charity-led drug discovery syndicates access the expertise and resources they need quickly and efficiently.

Charnwood Molecular are delighted to have joined this CRO network, providing industry, particularly for SMEs, translational academics and charities, with access to a full range of synthetic and medicinal chemistry services for Drug Discovery and early Drug Development.

You can find out more about Medicines Discovery Catapult on their website.

Charnwood Molecular Joins CRO Network